The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction (Q77762865)
Jump to navigation
Jump to search
scientific article published on 01 May 1999
Language | Label | Description | Also known as |
---|---|---|---|
English | The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction |
scientific article published on 01 May 1999 |
Statements
The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction (English)
J M Lenhard
M E Lancaster
M A Paulik
J E Weiel
J G Binz
S S Sundseth
B A Gaskill
R M Lightfoot